Pharvaris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Target enrollment achieved in RAPIDe-3, a pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, strengthening confidence in clinical timelinesEnrollment underway in ...
sf48m
Homelessness and Supportive Housing
An equity-driven plan to prevent and end homelessness in San Francisco 2023-2028. Data and Reports See data from the Homelessness Response System, recent reports submitted to the Board of Supervisors, ...